Available Technologies

Browse Penn-owned technologies available for licensing.


Search Results - taku kambayashi

3 Results Sort By:
Topical Treatment for Autoimmune Disorders
Treatment method for autoimmune diseases such as diabetes, multiple sclerosis, atherosclerosis, and rheumatoid arthritis using skin application of a vitamin D analog where topical treatment leads to systemic immunoregulation. Problem: Immunomodulatory drugs are typically administered systemically and often lead to severe side effects. Moreover,...
Published: 1/28/2020   |   Inventor(s): Taku Kambayashi
Category(s): Medical Devices, Therapeutics & Vaccines
Sweat Your Fat: Topical or systemic treatment of obesity and NASH by inducing secretion of lipids through skin
Topical treatment leading to upregulation of TSLP, recombinant TSLP, or TSLP expression by viral vectors use for weight loss and weight gain prevention in treatment of obesity, obesity-related disorders, NASH, and Type 2 Diabetes. Overview Technology: Previously Dr. Kambayashi has discovered that topical administration of a vitamin D3 analog MC903...
Published: 5/24/2019   |   Inventor(s): Taku Kambayashi
Category(s): Therapeutics & Vaccines
Inhibiting diacylglycerol kinase (DGK) for asthma treatment
ediators from T helper 2 (Th2) cells and non-immune effectors, such as smooth muscle shortening, which causes airway obstruction during an asthmatic attack. Treatments targeting inflammatory mediators do not always lead to a reduction in airway hyper-responsiveness. Thus, alternate ways to target both inflammatory and non-immune effectors are needed...
Published: 2/26/2019   |   Inventor(s): Taku Kambayashi
Keywords(s): Asthma
Category(s): Therapeutics & Vaccines